OTHER × Adenocarcinoma Of Esophagus × Irinotecan × Clear all mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Phase 3 Recruiting
382 enrolled
GRACIE
Phase 2 Recruiting
88 enrolled
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Phase 4 Recruiting
36 enrolled
Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Phase 2 Completed
245 enrolled 15 charts
Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Phase 2 Completed
40 enrolled
Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
Phase 2 Completed
51 enrolled
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
Phase 2 Completed
82 enrolled 9 charts
Phase II Study of Irinotecan and Panitumumab
Phase 2 Completed
24 enrolled 10 charts
Docetaxel and Irinotecan in Treating Patients With Advanced Cancer of the Esophagus or Stomach
Phase 2 Completed
47 enrolled
Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer
Phase 1 Terminated
23 enrolled
Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer
Phase 2 Completed
34 enrolled 5 charts
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin
Phase 2 Completed
16 enrolled 6 charts
Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer
Phase 2 Completed
19 enrolled
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer
Phase 1 Completed
23 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
Phase 1 Completed
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
Phase 2 Completed
Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer
Phase 1 Completed
27 enrolled
Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer
Phase 2 Completed
14 enrolled